Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

RY-023, a specific drug, can improve early stage memory learning without affecting general activity in rats, but it's less effective for later learning stages and doesn't impact memory recall.

Insulin-lowering medications show promise for PCOS symptoms but can't be the main treatment yet due to limited long-term research.

Both finasteride and drospirenone treatments improved symptoms and increased pregnancy rates in women with polycystic ovary syndrome.

Topiramate may help improve disruptive behaviors in children with bipolar disorder.

Ziziphus spina-christi leaf extract lowered blood sugar and protected organs in diabetic rats.

Probiotics and synbiotics may help with PCOS symptoms, but more research is needed.

Topical glycopyrrolate lotion helped reduce excessive sweating from eating in a diabetic man.

Monitoring for adverse effects in clinical treatments is crucial.

GLP-1 therapies can cause hair loss, but hair often regrows after stopping or reducing the drug.

A woman with Parkinson's disease experienced hair loss from the Parkinson's medication pramipexole, which improved after stopping the drug.

GLP-1 receptor agonists help women with PCOS lose weight and improve health, but more research is needed on long-term effects.

Lifestyle changes are more effective than metformin for reducing type 2 diabetes risk.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Pregnenolone might help manage movement issues caused by Parkinson's disease treatment without reducing the medicine's effectiveness.

Repaglinide-loaded liponiosomal hybrids improve blood sugar control and insulin release better than regular Repaglinide.

ZD1839 (Iressa) causes skin and hair side effects, treatable with tretinoin cream and minocycline.

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.

Ro 10-9359 is an effective treatment for severe psoriasis but can cause side effects.

Rimegepant causes more nausea and skin issues, while ubrogepant causes more muscle issues; personalized treatment is important.

Divalproex sodium can unexpectedly cause agitation and hyperactivity in some patients.

Rosiglitazone may be better than metformin for insulin resistance in PCOS, but more research is needed on certain biomarkers.

GLP-1 receptor agonists may increase the risk of hair loss, especially non-scarring types, due to weight loss-related nutrient deficiencies.

Some drugs can cause serious side effects, like hypoglycemia from mix-ups, skin reactions, or depression, and while penicillamine may help rheumatoid arthritis more than auranofin, it has more severe side effects.

The treatment cleared psoriasis in some patients but caused side effects in most.

Finasteride raises suicide-linked aggression and stops clozapine's positive effects in schizophrenia animals.

Finasteride improved symptoms in a psychotic patient, but more research is needed.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.